Ø  Effective Yield of up to 9.95% per annum

Ø  Credit Rating: “CRISIL AA-/Negative (pronounced as CRISIL double A minus rating with negative outlook)” and “ACUITE AA” (pronounced as ACUITE double A rating with negative outlook)

Ø  Trading in dematerialized form only

Ø  Allotment on date priority basis i.e., on first come first serve basis, based on the date of upload of each application into the electronic book with the Stock Exchange, in each Portion subject to the Allocation Ratio.

MUMBAI, 5^th JULY, 2022 (GPN): Edelweiss Broking Limited today announced the public issue of Secured Redeemable Non-Convertible Debentures (NCDs) of face value of ₹ 1,000 each, aggregating up to ₹ 150 Cr (“Base Issue”), with an option to retain over-subscription up to ₹ 150 Cr aggregating up to ₹ 300 Cr (“Issue”).

At least 90% from the net proceeds of the Issue will be used for working capital purpose and the balance of the net proceeds is proposed to be utilized for general corporate purposes, subject to such utilization not exceeding 10% of the amount raised in the Issue, in compliance with the Securities and Exchange Board of India (Issue and Listing of Non-Convertible Securities) Regulations, 2021 (“SEBI NCS Regulations”).

The NCDs carry fixed coupon ranging from 8.75% to 9.95% per annum and have tenor of 24 months / 36 months / 60 months / 120 months available with various interest payment options like monthly, annual and cumulative.

The additional incentive will be maximum of 0.20% p.a. for all Category of Investors in the proposed Issue, who are also holders of NCD(s)/Bond(s) previously issued by our Company, and/ or ECL Finance Limited, Edelweiss Financial Services Limited, Edelweiss Housing Finance Limited, Edelweiss Retail Finance Limited and Edelweiss Finance & Investments Limited as the case may be, and/or are equity shareholder(s) of Edelweiss Financial Services Limited as the case may be, on the deemed date of allotment.

The NCDs proposed to be issued under this Issue have been rated “CRISIL AA-/Negative (pronounced as CRISIL double A minus rating with negative outlook)” and “ACUITE AA” (pronounced as ACUITE double A rating with negative outlook).

The Issue opens on Tuesday, July 5, 2022 and closes on Tuesday, July 26, 2022 with an option of early closure. The NCDs are proposed to be listed on BSE Limited (“BSE”) to provide liquidity to the investors.

Equirus Capital Private Limited and Edelweiss Financial Services Limited* are the Lead Managers to this Issue.-Ends.

About Edelweiss Broking Limited

Edelweiss Broking Ltd. is a technology driven Securities Company in India that offers a wide range of financial services including broking services, distribution of financial products, short term funding for employee stock option schemes and margin trade financing facility. The Company are the one of the leading brokers and distributors in India. The Company offers broking services through their proprietary state of the art Website, Mobile Application, Terminal and API based trading platforms. The Company has over 0.3 million of active client base and ₹ 1.5 trillion of client assets spread across wide number of active broking accounts as of March 31, 2022.

Edelweiss Broking Ltd. is a wholly owned subsidiary of Edelweiss Securities Limited. Apart from Edelweiss Securities Limited, PAGAC Ecstasy Pte. Ltd. has also been categorized as the Promoter of the Company. Pacific Alliance Group (PAG) is one of the largest Asia focused alternative investment manager with approximately US$50 billion in assets under management.

To learn more about the Company and its offerings, please visit: https://www.edelweiss.in/